Ignite Creation Date:
2024-05-05 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00528333
Status:
COMPLETED
Last Update Posted:
2015-01-07
First Post:
2007-09-10
Brief Title:
A Study of Lintuzumab SGN-33 in Combination With Low Dose Cytarabine in Patients 60 Years With AML
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-10
First Submit QC Date:
September 11 2007
Study First Post Date:
2007-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2011-10-07
Disp First Submit QC Date:
October 7 2011
Disp First Post Date:
2011-10-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-12-17
Last Update Post Date:
2015-01-07
Last Update Post Date Type:
ESTIMATED